A randomised non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castration-resistant prostate cancer
Titel:
A randomised non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castration-resistant prostate cancer
Auteur:
Hussain, Maha Rathkopf, Dana Liu, Glenn Armstrong, Andrew Kelly, Wm. Kevin Ferrari, Anna Hainsworth, John Joshi, Adarsh Hozak, Rebecca R. Yang, Ling Schwartz, Jonathan D. Higano, Celestia S.